U.S. Alzheimer's Disease Medication Markets

Table of Contents

1 EXECUTIVE SUMMARY

• Executive Summary
  • Introduction

2 TOTAL MARKET INTRODUCTION

• Research Scope and Segmentation
  • Scope and Segmentation
  • Research Methodology
• Disease Overview and Treatment Options
  • Disease Overview
  • Disease Progression
  • Disease Causes and Risk Factors
  • Disease Burden
  • Diagnosis
  • Treatment Overview
• Total Market Introduction
  • Introduction
  • Competitive Structure
  • Market Engineering Measurements
  • Unmet Needs in the Alzheimer' s Disease Medication Market
  • Patient Forecasts
  • Revenue Forecasts
  • Market Share Analysis
• General Market Trends
  • Industry Challenges
  • Market Drivers
  • Market Restraints
• Strategies for Growth
  • Strategic Recommendations

3 CHOLINESTERASE INHIBITORS MARKET

• Market Overview
  • Introduction
  • Market Engineering Measurements
• Product Analysis
  • FDA-approved Products
  • Pipeline Analysis
• Market Forecasts
  • Aricept Forecast
  • Exelon Forecast
  • Razadyne Forecast
  • Cholinesterase Inhibitors Market
  • Market Share Analysis

4 NMDA RECEPTOR ANTAGONISTS MARKET

• Market Overview
  • Introduction
  • Market Engineering Measurements
• Product Analysis
  • Namenda
  • Pipeline Analysis
• Market Forecasts
  • Namenda Forecast

5 NEW MECHANISM PRODUCTS IN DEVELOPMENT

• Overview
  • Introduction
  • Amyloid Plaque Inhibitors Pipeline Analysis
  • Secretase Inhibitors Pipeline Analysis
  • Immunotherapeutics Pipeline Analysis
  • Other New Mechanism Drugs Pipeline Analysis
• Market Forecasts
  • Alzhemed Forecast
  • Flurizan Forecast

6 APPENDIX

• Decision Support Database
  • Number of Alzheimer' s Patients
  • Alzheimer' s Disease Deaths
  • Total Healthcare Expenditure
  • Male Population 65 and Above
  • Female Population 65 and Above